Header Logo

Connection

Ryan Svoboda to Melanoma

This is a "connection" page, showing publications Ryan Svoboda has written about Melanoma.
Connection Strength

1.779
  1. Svoboda RM, Glazer AM, Farberg AS, Cowdrey MCE, Rigel DS. Melanoma Reporting Practices of United States Dermatologists. Dermatol Surg. 2018 11; 44(11):1391-1395.
    View in: PubMed
    Score: 0.480
  2. Svoboda RM, Prado G, Mirsky RS, Rigel DS. Assessment of clinician accuracy for diagnosing melanoma on the basis of electrical impedance spectroscopy score plus morphology versus lesion morphology alone. J Am Acad Dermatol. 2019 Jan; 80(1):285-287.
    View in: PubMed
    Score: 0.475
  3. Svoboda RM, Glazer AM, Farberg AS, Rigel DS. Factors Affecting Dermatologists' Use of a 31-Gene Expression Profiling Test as an Adjunct for Predicting Metastatic Risk in Cutaneous Melanoma. J Drugs Dermatol. 2018 May 01; 17(5):544-547.
    View in: PubMed
    Score: 0.463
  4. Prado G, Svoboda RM, Rigel DS. What's New in Melanoma. Dermatol Clin. 2019 Apr; 37(2):159-168.
    View in: PubMed
    Score: 0.122
  5. Mirsky R, Prado G, Svoboda R, Glazer A, Rigel D. Management Decisions Made by Physician Assistants and Nurse Practitioners in Cutaneous Malignant Melanoma Patients: Impact of a 31-Gene Expression Profile Test J Drugs Dermatol. 2018 11 01; 17(11):1220-1223.
    View in: PubMed
    Score: 0.120
  6. Svoboda RM, Friedman RJ, Rigel DS. Skin Self-examination for Skin Cancer Prevention. JAMA. 2018 08 21; 320(7):720-721.
    View in: PubMed
    Score: 0.118
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.